![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|22|29|4596-4603
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.22, Iss.29, 2016-09, pp. : 4596-4603
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Duration of Dual Antiplatelet Therapy After Coronary Stenting
Current Pharmaceutical Design, Vol. 22, Iss. 29, 2016-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bisphosphonates and Atrial Fibrillation: Systematic Review and Meta-Analysis
By >
Drug Safety, Vol. 32, Iss. 3, 2009-01 ,pp. :